RICHMOND, VA Bright Path Pharmaceuticals, LLC (privately held) today announced that the Medicines for All Institute, a joint venture between Virginia Commonwealth University and the Gates Foundation, has selected BPP as its' first commercial innovation manufacturing...
RICHMOND, VA Bright Path Pharmaceuticals, LLC (privately held), today announced that ChemWerth's Chief Scientific Officer, Dr. Xiping Su, has joined the Board of the company following their investment in BPP. Xiping Su, Ph.D., is organic chemistry and ChemWerth’s head...
CHARLOTTE, NC Bright Path Pharmaceuticals, LLC (privately held) today announced that Todd N. Smith, Chairman and CEO of Novum Pharma will join the Board. Mr. Smith has twenty-five years of pharmaceutical, medical device and biotechnology general management experience...